Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 10, 2006, Pages 4057-4063

  Hehenkamp, Wouter J K ^a   Looman, Caspar W N ^b   Themmen, Axel P N ^b   De Jong, Frank H ^b   Te Velde, E R ^c   Broekmans, Frank J M ^c  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HUMAN; MENSTRUAL CYCLE; OVULATION; PATIENT SELECTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 33749567109     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0331     Document Type: Article

References (38)

1. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
2. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP 2002 Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076-1084
3. Schmidt KL, Kryger-Baggesen N, Byskov AG, Andersen CY 2005 Anti-Mullerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol 234:87-93
4. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899
5. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77-83
6. Gruijters MJ, Visser JA, Durlinger AL, Themmen AP 2003 Anti-Mullerian hormone and its role in ovarian function. Mol Cell Endocrinol 211:85-90
7. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J 2003 Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18:328-332
8. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, Volpe A 2004 Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 19:2738-2741
9. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT 1996 Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576
10. Hudson PL, Dougas I, Donahoe PK, Cate RL, Epstein J, Pepinsky RB, MacLaughlinDT1990 An immunoassay to detect human Mullerian inhibiting substance in males and females during normal development. J Clin Endocrinol Metab 70:16-22
11. Lee MM, Misra M, Donahoe PK, MacLaughlin DT 2003 MIS/AMH in the assessment of cryptorchidism and intersex conditions. Mol Cell Endocrinol 211:91-98
12. Buzi F, Pilotta A, Dordoni D, Lombardi A, Zaglio S, Adlard P 1998 Pelvic ultrasonography in normal girls and in girls with pubertal precocity. Acta Paediatr 87:1138-1145
13. Peters H, Himelstein-Braw R, Faber M 1976 The normal development of the ovary in childhood. Acta Endocrinol (Copenh) 82:617-630
14. De Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Anti-Mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362
15. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J 2003 Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18:323-327
16. Van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH, Themmen AP 2002 Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17:3065-3071
17. Van Rooij IA, Tonkelaar I, Broekmans FJ, Looman CW, Scheffer GJ, de Jong FH, Themmen AP, te Velde ER 2004 Anti-Mullerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause 11:601-606
18. Van Rooij IA, Broekmans FJ, Scheffer GJ, Looman CW, Habbema JD, de Jong FH, Fauser BJ, Themmen AP, te Velde ER 2005 Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 83:979-987
19. Fanchin R, Mendez Lozano DH, Louafi N, Chour-Frydman N, Frydman R, Taieb J 2005 Dynamics of serum anti-Mullerian hormone levels during the luteal phase of controlled ovarian hyperstimulation. Hum Reprod 20:747-751
20. Hazout A, Bouchard P, Seifer DB, Aussage P, Junca AM, Cohen-Bacrie P 2004 Serum antimullerian hormone/mullerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Fertil Steril 82:1323-1329
21. Cook CL, Siow Y, Taylor S, Fallat ME 2000 Serum Mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 73:859-861
22. Scheffer GJ, Broekmans FJ, Dorland M, Habbema JD, Looman CW, te Velde ER 1999 Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril 72:845-851
23. Van Zonneveld P, Scheffer GJ, Broekmans FJ, Blankenstein MA, de Jong FH, Looman CW, Habbema JD, te Velde ER 2003 Do cycle disturbances explain the age-related decline of female fertility? Cycle characteristics of women aged over 40 years compared with a reference population of young women. Hum Reprod 18:495-501
24. Check JH, Adelson HG, Dietterich C, Stern J 1990 Pelvic sonography can predict ovum release in gonadotrophin-treated patients as determined by pregnancy rate. Hum Reprod 5:234-236
25. Janssen-Caspers HA, Kruitwagen RF, Wladimiroff JW, de Jong FH, DrogendijkAC1986 Diagnosis of luteinized unruptured follicle by ultrasound and steroid hormone assays in peritoneal fluid: a comparative study. Fertil Steril 46:823-827
26. Batschelet E 1981 Circular statistics in biology. London: Academic Press
27. Macklon NS, Fauser BC 2001 Follicle-stimulating hormone and advanced follicle development in the human. Arch Med Res 32:595-600
28. Visser JA, de Jong FH, Laven JS, Themmen AP 2006 Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 131:1-9
29. Pache TD, Wladimiroff JW, de Jong FH, Hop WC, Fauser BC 1990 Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril 54:638-642
30. Baerwald AR, Adams GP, Pierson RA 2003 Characterization of ovarian follicular wave dynamics in women. Biol Reprod 69:1023-1031
31. Dieleman SJ, Bevers MM 1993 Folliculogenesis and oocyte maturation in superovulated cattle. Mol Reprod Dev 36:271-273
32. Ginther OJ, Bergfelt DR, Beg MA, Kot K 2002 Role of low circulating FSH concentrations in controlling the interval to emergence of the subsequent follicular wave in cattle. Reproduction 124:475-482
33. Penarrubia J, Fabregues F, Manau D, Creus M, Casals G, Casamitjana R, Carmona F, Vanrell JA, Balasch J 2005 Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist-gonadotropin treatment. Hum Reprod 20:915-922
34. Fanchin R, Taieb J, Lozano HM, Ducot B, Frydman R, Bouyer J 2005 High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 20:923-927
35. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER 2004 Predicting poor ovarian response in IVF: use of repeat basal FSH measurement. J Reprod Med 49:187-194
36. Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER 2004 Impact of repeated antral follicle counts on the prediction of poor ovarian response in women undergoing in vitro fertilization. Fertil Steril 81:35-41
37. Hendriks DJ, Broekmans FJ, Bancsi LF, Looman CW, de Jong FH, te Velde ER 2005 Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet 22:65-73
38. Hendriks DJ, Broekmans FJ, Bancsi LF, de Jong FH, Looman CW, te Velde ER 2005 Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve. Hum Reprod 20:163-169